Is THC legal in France?

Formal status

Finished-product THC threshold is 0.3% (arrete du 30 decembre 2021, raised from 0.2% to align with EU Regulation 2021/2115), applying to all cannabis-derived products sold in France. This threshold is comfortably met by Gavarres' full-spectrum extract (under 0.2%). Separately, any ingestible product containing cannabinoids - regardless of THC content - falls under the May 2026 DGAL Novel Food enforcement, which is the actual binding constraint.

Do we sell here?

Yes, for now: Sleep spray, Sleep capsules.

The THC threshold itself isn't the concern here - our formula runs comfortably under France's limit. Trace THC is a natural part of a full-spectrum extract, so what we're actually watching is the same broader ingestible-format enforcement that applies to our CBD and CBN content.

Outlook

The 0.3% threshold itself is not the live risk - it is comfortably met. The binding constraint is the same DGAL ingestible-cannabinoid ban affecting CBD and CBN; same autumn 2026 Conseil d'Etat case to watch.

Timeline

December 2021

Arrete sets finished-product THC threshold at 0.3% (up from 0.2%), aligning with EU Regulation 2021/2115; applies to oils, flowers, resins, cosmetics, e-liquids

CBUD - Reglementation THC France 2026

March 2026

French customs arrete grants power to intercept small e-commerce parcels after they enter French territory, even if already cleared customs in another EU member state - closes the EU-transit workaround for cross-border sellers

France Info

May 2026

DGAL 2026 national control plan takes effect: bans sale of any ingestible cannabinoid product (oils/tinctures, gummies, capsules, teas, drinks) under strict Novel Food enforcement; flower, resin, e-liquids, and topical cosmetics remain unaffected

France Cannabidiol - CBD legal en France 2026

July 2026

Conseil d'Etat rejects industry's emergency suspension request (refere), decision n.516668; ban remains in force; substantive case on the doctrine's legality pushed to autumn 2026

France-Epargne